Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents-Reference-Cited by-同舟云学术

Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents

Published:2016-07 Issue: Volume:160 Page:49-58
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Workman David G.,Hunter Michael,Dover Lynn G.,Tétard David^ORCID

Funder

Healthcare Infection Society

Northumbria University

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference85 articles.

1. Origins and Evolution of Antibiotic Resistance

2. New Engl;Arias;J. Med.,2009

3. The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies

4. Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm

5. The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals;Inorganic Chemistry;2023-08-17

2. Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?;International Journal of Molecular Sciences;2023-03-24

3. Recent advances in therapeutical applications of the versatile hydroxypyridinone chelators;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2022-01-16

4. Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease;Dalton Transactions;2022

5. Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors;RSC Medicinal Chemistry;2022